Aspirin

Description

No relevant information is available for SPL code 34089-3.

Uses and Indications

This drug is indicated for the relief of symptoms in adults and children aged 12 years and older. The recommended dosage is 1 to 2 tablets every 4 hours as needed, with a maximum of 12 tablets in a 24-hour period unless otherwise directed by a healthcare professional.

Use in children under 12 years is not recommended unless directed by a doctor.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

No dosage and administration information is available for this product. Healthcare professionals are advised to consult the prescribing information or relevant clinical guidelines for specific dosing recommendations and administration techniques.

Contraindications

Use is contraindicated in individuals with a known allergy to aspirin or any other pain reliever or fever reducer. Due to the potential for severe allergic reactions, administration in these patients is not recommended.

Warnings and Precautions

Children and teenagers who are experiencing or recovering from chickenpox or flu-like symptoms should not use this product due to the risk of Reye's syndrome. If any changes in behavior accompanied by nausea and vomiting occur while using this product, it is imperative to consult a healthcare professional, as these symptoms may indicate the onset of this rare but serious condition.

Aspirin may provoke severe allergic reactions in some individuals. Symptoms of such reactions can include facial swelling, shock, hives, and asthma-related wheezing. Immediate medical attention should be sought if any of these symptoms occur.

This product contains a nonsteroidal anti-inflammatory drug (NSAID), which carries a risk of severe stomach bleeding. The likelihood of this adverse effect is increased in individuals who are 60 years of age or older, those taking anticoagulants or steroid medications, individuals using other NSAIDs (including aspirin, ibuprofen, or naproxen), those with a history of stomach ulcers or bleeding disorders, individuals consuming three or more alcoholic beverages daily while using this product, and those who exceed the recommended dosage or duration of use.

Healthcare professionals should advise patients to discontinue use and seek medical attention if they experience any signs of stomach bleeding, which may include feeling faint, vomiting blood, having bloody or black stools, or experiencing persistent stomach pain. Additionally, patients should seek immediate medical help if they experience an allergic reaction, ringing in the ears, loss of hearing, worsening pain lasting more than three days, redness or swelling, or the emergence of new symptoms, as these may indicate a serious underlying condition.

In the event of an overdose, it is crucial to obtain emergency medical assistance or contact a Poison Control Center at 1-800-222-1222 without delay.

Before initiating use of this product, patients should consult a healthcare professional if they have a history of asthma, if the stomach bleeding warning applies to them, or if they have a history of stomach issues such as heartburn. Additionally, individuals with high blood pressure, heart disease, liver cirrhosis, or kidney disease, as well as those taking diuretics, should seek medical advice prior to use. Patients taking prescription medications for gout, diabetes, or arthritis should also consult a healthcare professional or pharmacist before using this product.

Side Effects

Patients using this product should be aware of several serious adverse reactions associated with its use. Reye's syndrome is a rare but serious illness that can occur in children and teenagers who have or are recovering from chickenpox or flu-like symptoms. If patients experience changes in behavior accompanied by nausea and vomiting while using this product, they should consult a doctor immediately, as these may be early signs of Reye's syndrome.

Additionally, there is an allergy alert associated with this product. Aspirin may cause severe allergic reactions, which can manifest as facial swelling, shock, hives, or asthma symptoms such as wheezing. Patients experiencing any signs of an allergic reaction should seek medical help right away.

This product contains a nonsteroidal anti-inflammatory drug (NSAID), which may increase the risk of severe stomach bleeding. The risk is heightened in patients who are 60 years of age or older, those taking blood-thinning medications or steroids, individuals using other NSAIDs (including aspirin, ibuprofen, or naproxen), and patients with a history of stomach ulcers or bleeding problems. Furthermore, patients who consume three or more alcoholic drinks daily while using this product or those who take it for longer than directed are also at increased risk.

Patients should discontinue use and consult a doctor if they experience any signs of stomach bleeding, which may include feeling faint, vomiting blood, having bloody or black stools, or experiencing stomach pain that does not improve. Other reasons to stop use and seek medical advice include the occurrence of an allergic reaction, ringing in the ears or loss of hearing, worsening pain lasting more than three days, presence of redness or swelling, or the emergence of new symptoms.

Before using this product, patients should consult a doctor if they have asthma, if the stomach bleeding warning applies to them, or if they have a history of stomach problems such as heartburn. Additionally, individuals with high blood pressure, heart disease, liver cirrhosis, or kidney disease, as well as those taking diuretics, should seek medical advice prior to use. Patients taking prescription medications for gout, diabetes, or arthritis should also consult a doctor or pharmacist before using this product.

Drug Interactions

Patients taking anticoagulants or steroid medications may experience significant drug interactions that necessitate careful monitoring. The concurrent use of these agents with nonsteroidal anti-inflammatory drugs (NSAIDs), including both prescription and nonprescription options such as aspirin, ibuprofen, and naproxen, can increase the risk of bleeding. It is advisable to monitor patients closely for signs of hemorrhage and consider dosage adjustments as necessary.

Additionally, the use of prescription medications for gout, diabetes, or arthritis may also lead to potential interactions. While specific mechanisms or clinical effects are not detailed, healthcare providers should remain vigilant and assess the need for monitoring or dosage modifications when these medications are prescribed in conjunction with the aforementioned drug classes.

No specific laboratory test interactions have been identified in the provided data.

Packaging & NDC

Below are the non-prescription pack sizes of Aspirin. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should not use this product unless directed by a doctor. For adolescents aged 12 years and older, the recommended dosage is 1 to 2 tablets every 4 hours as needed for symptom relief, with a maximum of 12 tablets in a 24-hour period unless otherwise directed by a healthcare professional.

Caution is advised for children and teenagers who have or are recovering from chickenpox or flu-like symptoms, as the use of this product in such cases may increase the risk of Reye's syndrome, a rare but serious condition. If any changes in behavior accompanied by nausea and vomiting occur, it is important to consult a doctor promptly, as these may be early signs of Reye's syndrome.

Geriatric Use

Elderly patients, particularly those aged 60 and older, are at an increased risk of severe stomach bleeding when using this product, which contains a nonsteroidal anti-inflammatory drug (NSAID). The risk is further heightened in patients who are concurrently taking anticoagulants or steroid medications, as well as those using other NSAIDs, whether prescription or over-the-counter, such as aspirin, ibuprofen, or naproxen.

Additionally, geriatric patients with a history of stomach ulcers or bleeding problems should exercise caution when using this product. It is also important to note that consuming three or more alcoholic drinks daily while using this NSAID can significantly increase the risk of gastrointestinal complications.

Healthcare providers should carefully monitor elderly patients for signs of gastrointestinal bleeding and consider dose adjustments or alternative therapies as necessary to mitigate these risks. It is essential to adhere to the recommended dosage and duration of use to minimize potential adverse effects in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional before using this medication. Aspirin use during the last trimester of pregnancy is particularly cautioned against, as it may lead to adverse effects on the unborn child and complications during delivery. Therefore, it is essential that pregnant patients only use aspirin in this period if explicitly directed by a healthcare provider.

Lactation

Lactating mothers are advised to consult a health professional before using this medication. It is particularly important to avoid the use of aspirin during the last three months of pregnancy unless specifically directed by a physician, as it may pose risks to the unborn child or lead to complications during delivery. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when considering its use in lactating individuals.

Renal Impairment

There is no specific information regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this population to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor patients closely for any signs or symptoms that may arise following an overdose. Common symptoms may include, but are not limited to, alterations in vital signs, neurological disturbances, and gastrointestinal symptoms.

In the event of an overdose, immediate medical attention should be sought. Supportive care is the cornerstone of management, which may include the following steps:

1. Assessment: Conduct a thorough evaluation of the patient's clinical status, including vital signs and level of consciousness.

2. Supportive Care: Provide symptomatic treatment as necessary, which may involve intravenous fluids, oxygen supplementation, or other interventions based on the patient's condition.

3. Decontamination: If the overdose is recent and the patient is alert, activated charcoal may be administered to limit further absorption of the substance.

4. Consultation: Engage with a poison control center or toxicology specialist for guidance on specific antidotes or advanced management strategies, if applicable.

Healthcare professionals should remain vigilant and prepared to implement these measures promptly to mitigate the potential effects of an overdose.

Nonclinical Toxicology

It is especially important not to use aspirin during the last three months of pregnancy unless specifically directed by a healthcare professional, as it may lead to complications for the unborn child or during delivery. No specific non-teratogenic effects have been identified in the available data. Additionally, there are no details regarding nonclinical toxicology or animal pharmacology and toxicology provided in the current information.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. In the event of an overdose, patients should be instructed to seek medical help immediately or contact a Poison Control Center at 1-800-222-1222.

Patients must be informed not to use this medication if they have a known allergy to aspirin or any other pain reliever or fever reducer. It is essential to counsel patients to stop using the medication and consult a doctor if they experience any signs of stomach bleeding, which may include feeling faint, vomiting blood, having bloody or black stools, or experiencing stomach pain that does not improve. Additionally, patients should seek immediate medical attention if they experience an allergic reaction, ringing in the ears, loss of hearing, worsening pain that lasts more than three days, redness or swelling, or the emergence of new symptoms, as these could indicate a serious condition.

Patients should be encouraged to consult with their healthcare provider before using this medication if they have a history of asthma, if the warning for stomach bleeding applies to them, or if they have a history of stomach problems such as heartburn. Furthermore, those with high blood pressure, heart disease, liver cirrhosis, or kidney disease, as well as individuals taking diuretics, should also seek medical advice prior to use.

Lastly, patients taking prescription medications for gout, diabetes, or arthritis should be advised to consult with their doctor or pharmacist before using this medication to avoid potential interactions.

Storage and Handling

The product is supplied with an expiration date clearly indicated on the package. It should be stored at a controlled room temperature of 25°C (77°F). Temporary excursions are permissible within the range of 15° to 30°C (59° to 86°F). Proper storage conditions are essential to maintain the integrity and efficacy of the product.

Additional Clinical Information

The medication is administered orally. Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. It is particularly crucial to avoid aspirin during the last trimester of pregnancy unless specifically directed by a physician, as it may pose risks to the unborn child or lead to complications during delivery. No further information is available regarding laboratory tests, abuse potential, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Aspirin, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)